Melissa B. Epperly, Chief Financial Officer at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 17,338 shares at $11.54 ($200K) on 2024-02-02, disclosed to the SEC on 2024-02-05.
Seasonal sale ($200k) by Chief Financial Officer — this insider has traded ZNTL in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.54 | 8,669 | $100K | 50.0% |
| 2 | $11.54 | 8,669 | $100K | 50.0% |
| Total | $11.54 avg | 17,338 | $200K | 100% |
| Filing → |
| ROIV | SELL | 2026-07-01 | $610K | — | Filing → |
| ROIV | SELL | 2026-03-18 | $1.2M | — | Filing → |
| ZNTL | SELL | 2024-02-12 | $29K | — | Filing → |